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Flavin nucleotides act as electron shuttles mediating reduction 
of the [2Fe-2S] clusters in mitochondrial outer membrane protein 
mitoNEET
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Huangen Ding*
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Abstract
MitoNEET, a primary target of type II diabetes drug pioglitazone, has an essential role in 
regulating energy metabolism, iron homeostasis, and production of reactive oxygen species in 
mitochondria. Structurally, mitoNEET is anchored to the mitochondrial outer membrane via its N-
terminal transmembrane α-helix. The C-terminal cytosolic domain of mitoNEET hosts a redox 
active [2Fe-2S] cluster via three cysteine and one histidine residues. Here we report that the 
reduced flavin nucleotides can rapidly reduce the mitoNEET [2Fe-2S] clusters under anaerobic or 
aerobic conditions. In the presence of NADH and flavin reductase, about 1 molecule of flavin 
nucleotide is sufficient to reduce 100 molecules of the mitoNEET [2Fe-2S] clusters in 4 minutes 
under aerobic conditions. The electron paramagnetic resonance (EPR) measurements show that 
flavin mononucleotide (FMN), but not flavin adenine dinucleotide (FAD), has a specific 
interaction with mitoNEET. Molecular docking models further reveal that flavin mononucleotide 
binds mitoNEET at the region between the N-terminal transmembrane α-helix and the [2Fe-2S] 
cluster binding domain. The closest distance between the [2Fe-2S] cluster and the bound flavin 
mononucleotide in mitoNEET is about 10 Å, which may facilitate rapid electron transfer from the 
reduced flavin nucleotide to the [2Fe-2S] cluster in mitoNEET. The results suggest that flavin 
nucleotides may act as electron shuttles to reduce the mitoNEET [2Fe-2S] clusters and regulate 
mitochondrial functions in human cells.
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Human mitochondrial outer membrane protein mitoNEET was initially identified as a target 
of type II diabetes drug pioglitazone [1]. While deletion of mitoNEET in mice significantly 
decreases oxidative phosphorylation activity in mitochondria [2], increased expression of 
mitoNEET in adipocytes enhances lipid uptake and storage of the cells and inhibits 
mitochondrial iron transport into matrix [3]. In beta cells, increased expression of 
mitoNEET leads to hyperglycemia and glucose intolerance [4]. Misregulation of mitoNEET 
expression has also been attributed to the development of neurodegenerative disease [5, 6] 
and cardiovascular disease [7], breast cancer proliferation [8–10], browning of white adipose 
tissue [11], among other pathological conditions [12]. It has thus been proposed that 
mitoNEET is a key regulator for energy metabolism, iron homeostasis, and production of 
reactive oxygen species in mitochondria [13].
MitoNEET is a homodimer with each monomer containing an N-terminal transmembrane α-
helix (residues 14 to 32) anchored to the mitochondrial outer membrane [1]. The C-terminal 
cytosolic domain (residues 33–108) of mitoNEET hosts a redox active [2Fe-2S] cluster via a 
unique ligand arrangement of three cysteine and one histidine residues [14–16]. As 
mitochondria are the primary sites for iron-sulfur cluster biogenesis [17], several studies 
have suggested that mitoNEET may mediate transfer of iron-sulfur clusters assembled in 
mitochondria to target proteins in cytoplasm [18–21]. However, the cluster transfer occurs 
only when the mitoNEET [2Fe-2S] clusters are in oxidized state [18, 21], indicating the 
transfer process is controlled by the redox state of the [2Fe-2S] clusters [22, 23]. 
Alternatively, mitoNEET may directly regulate mitochondrial functions via the redox 
transition of the [2Fe-2S] clusters [4, 22–24], as mitoNEET forms complexes with multiple 
mitochondrial proteins including the Parkinson's disease associated protein Parkin [4, 25, 
26] and mitochondrial outer membrane import complex protein 1 (MTX1) [27].
Intracellular redox co-enzymes including nicotinamide adenine dinucleotide (NAD+), 
nicotinamide adenine dinucleotide phosphate (NADP+), flavin mononucleotide (FMN), and 
flavin adenine dinucleotide (FAD) are considered as natural biomarkers of metabolic 
activities and mitochondrial anomalies [28]. If mitoNEET is a key regulator of energy 
metabolism in mitochondria [13], it is expected that mitoNEET will have direct interactions 
with the redox co-enzymes in cells. Indeed, previous studies have shown that mitoNEET is 
able to bind NADP(H) (but not NAD(H)) [29], and that binding of NADPH in mitoNEET 
destabilizes the [2Fe-2S] clusters [29] and inhibits the [2Fe-2S] cluster transfer from 
mitoNEET to target proteins [30]. However, the interaction between mitoNEET and 
NADP(H) is fairly weak (with a dissociation constant of about 2.0 mM) [29]. Furthermore, 
both NADPH and NADH fail to reduce the mitoNEET [2Fe-2S] clusters under anaerobic or 
aerobic conditions [22, 23, 30]. Here, we report that the reduced flavin nucleotides can 
rapidly reduce the mitoNEET [2Fe-2S] clusters under anaerobic or aerobic conditions. The 
electron paramagnetic resonance (EPR) measurements show that flavin mononucleotide, but 
not flavin adenine dinucleotide, has a specific interaction with mitoNEET. Furthermore, 
molecular docking models reveal that flavin mononucleotide binds mitoNEET at the region 
between the N-terminal transmembrane α-helix and the [2Fe-2S] cluster binding domain. 
Such an arrangement may facilitate rapid electron transfer from the reduced flavin 
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nucleotide to the [2Fe-2S] clusters in mitoNEET. Our results suggest that mitoNEET may 
sense redox state of intracellular redox co-enzymes to modulate energy metabolism, iron 
homeostasis, and production of reactive oxygen species in mitochondria.
MATERIALS AND METHODS
1. Protein preparation
Escherichia coli flavin reductase (Fre) was prepared using an E. coli strain hosting an 
expression plasmid encoding Fre from the ASKA library [31]. Human mitochondrial outer 
membrane protein mitoNEET33–108 (containing residues 33–108) was purified as described 
in [23]. MitoNEET with deletion of the segment between Arg-33 and Ile-45 was prepared 
using the site-directed mutagenesis (Agilent co.), and confirmed by direct sequencing. The 
purity of purified proteins was greater than 95% as judged by electrophoresis analysis on a 
15% polyacrylamide gel containing SDS followed by staining with Coomassie Blue. The 
protein concentrations of mitoNEET and E. coli Fre were measured at 280 nm using an 
extinction coefficient of 8.6 and 26.4 mM−1cm−1, respectively. The UV-visible absorption 
spectra were measured in a Beckman DU640 UV-visible absorption spectrometer equipped 
with a temperature controller.
2. Iron and sulfide content analyses
The iron content of protein samples was determined using ferroZine [32] as described 
previously [33]. The sulfide contents of protein samples was determined according to the 
Siegel’s method [34]. Purified E. coli endonuclease III containing a stable [4Fe-4S] cluster 
[35] was used as a standard for the iron and sulfide content analyses in protein samples.
3. EPR measurements
The X-band Electron Paramagnetic Resonance (EPR) spectra were recorded using a Bruker 
model ESR-300 spectrometer equipped with an Oxford Instruments 910 continuous flow 
cryostat. Routine EPR conditions were: microwave frequency, 9.47 GHz; microwave power, 
10.0 mW; modulation frequency, 100 kHz; modulation amplitude, 1.2 mT; temperature, 30 
K; receiver gain, 2×105.
4. Chemicals
NADH, NADPH, Isopropyl-β-D-1-thiogalactopyranoside, kanamycin, and ampicillin were 
purchased from Research Product International co. FMN, FAD, and other chemicals were 
purchased from Sigma co. Extinction coefficients of 6.2 mM−1cm−1 at 340 nm, 12.5 
mM−1cm−1 at 445 nm, and 11.3 mM−1cm−1 at 450 nm were used for NADH/NADPH, FMN 
and FAD, respectively [28].
5. Molecular docking
The protocol for AutoDockVina-based molecular docking is a modification from Garret M. 
Morris’ (The Scripps Research Institute, La Jolla, CA) [36]. The validity of this protocol 
was established during other studies [37]. Partial conformational flexibility was allowed to 
the residues in direct contacts with targets. Docking is made based on binding energy 
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calculation using Lamarckian Genetic Algorithm implemented in AutoDock3 [36]. The 
detailed docking parameters per molecule are: the energy evaluations number = 1750000, 
the population size = 150, the trial number = 20, and the positional rms tolerance = 2.0 Å.
RESULTS
1. Reduced flavin nucleotides rapidly reduce the mitoNEET [2Fe-2S] clusters under aerobic 
conditions
Unlike NADPH or NADH, reduced flavin nucleotides (FMNH2 and FADH2) are not stable 
under aerobic conditions and not commercially available. To prepare FMNH2 or FADH2, we 
purified Escherichia coli flavin reductase (Fre) from an E. coli ASKA library strain [31]. 
Figure 1A shows that purified E. coli Fre does not have any prosthetic groups as reported in 
[38], and is fully active to reduce FMN/FAD to FMNH2/FADH2 using NADH as electron 
donor [39].
To monitor the redox state of the mitoNEET [2Fe-2S] clusters, we used the UV-visible 
absorption spectroscopy. Purified human mitoNEET has two major absorption peaks at 458 
nm and 540 nm, indicative of the oxidized [2Fe-2S] clusters in the protein [18, 22] (Figure 
1B, spectrum 1). When mitoNEET is incubated with a catalytic amount of purified E. coli 
Fre (Figure 1B, spectrum 2) or Fre and NADH (Figure 1B, spectrum 3) under aerobic 
conditions, the mitoNEET [2Fe-2S] clusters remain oxidized. However, when mitoNEET is 
incubated with E. coli Fre, NADH and FMN under aerobic conditions, the mitoNEET 
[2Fe-2S] clusters are fully reduced, as indicated by a new absorption peak at 420 nm (Figure 
1B, spectrum 4). Thus, while Fre or Fre/NADH fails to reduce the mitoNEET [2Fe-2S] 
clusters, FMN reduced by Fre and NADH can fully reduce the mitoNEET [2Fe-2S] clusters 
under aerobic conditions. Similar results are observed when FMN is replaced with FAD in 
the incubation solutions (data not shown).
In parallel experiments, we used the electron paramagnetic resonance (EPR) spectroscopy to 
evaluate the redox state of the mitoNEET [2Fe-2S] clusters in the above reaction solutions. 
While the oxidized mitoNEET [2Fe-2S] clusters are EPR silent, the reduced mitoNEET 
[2Fe-2S] clusters have a distinct EPR signal at g = 1.94 [23, 40]. Figure 1C shows that the 
mitoNEET [2Fe-2S] clusters are reduced only after mitoNEET is incubated with Fre, NADH 
and FMN or FAD (not shown). Thus, the mitoNEET [2Fe-2S] clusters can be efficiently 
reduced by the reduced flavin nucleotides under aerobic conditions.
2. Reversible reduction of the mitoNEET [2Fe-2S] clusters under aerobic conditions
Since the redox midpoint potential (Em7) of the mitoNEET [2Fe-2S] clusters is about 0 mV 
[24], the reduced [2Fe-2S] clusters in mitoNEET could be readily oxidized by oxygen under 
aerobic conditions. To test this idea, mitoNEET is pre-incubated with FMN and a limited 
amount of NADH under anaerobic conditions, followed by addition of a catalytic amount of 
flavin reductase (Fre). As shown in Figure 2A, addition of Fre leads to a rapid reduction of 
the mitoNEET [2Fe-2S] clusters under anaerobic conditions. When the reaction solution is 
exposed to air, the reduced mitoNEET [2Fe-2S] clusters are quickly oxidized (Figure 2B, 
spectrum 3). However, when additional NADH is added to the reaction solution, the 
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mitoNEET [2Fe-2S] clusters are re-reduced under aerobic conditions (Figure 2A). The 
results suggest that under aerobic conditions, a continuous supply of NADH is required for 
maintaining the reduced state of the mitoNEET [2Fe-2S] clusters in the presence of flavin 
reductase and flavin nucleotide. Thus, the redox state of the mitoNEET [2Fe-2S] clusters 
may be controlled by the reduced redox co-enzymes in cells under aerobic conditions.
3. Flavin nucleotides act as electron shuttles mediating reduction of the mitoNEET 
[2Fe-2S] clusters
Flavin reductase reduces flavin nucleotides using NADH as electron donor without tightly 
binding its substrates or products [39]. We assume that flavin nucleotides reduced by flavin 
reductase will diffuse from the enzyme to reduce the [2Fe-2S] clusters in mitoNEET. To 
explore this idea, mitoNEET (containing 10 µM [2Fe-2S] cluster) is pre-incubated with Fre 
(1 µM) and various concentrations of FMN under aerobic conditions. The reduction of the 
mitoNEET [2Fe-2S] clusters in solutions is initiated by adding NADH (100 µM). Figure 3A 
shows that without FMN, there is no reduction of the mitoNEET [2Fe-2S] clusters. As the 
concentration of FMN is increased from 0 to 0.2 µM in the incubation solution (Figure 3B–
F), the mitoNEET [2Fe-2S] clusters are quickly reduced under aerobic conditions.
The amounts of the reduced mitoNEET [2Fe-2S] clusters are measured after 4 min 
incubation with Fre, NADH and various concentrations of FMN or FAD, and plotted as a 
function of the flavin nucleotide concentrations. Figure 4A shows that about 0.1 µM FMN is 
sufficient to fully reduce 10 µM mitoNEET [2Fe-2S] clusters after 4 min incubation. Similar 
results are observed when FMN is replaced with FAD in the reaction solutions (Figure 4B). 
These results suggest that flavin nucleotides may act as electron shuttles to efficiently reduce 
the mitoNEET [2Fe-2S] clusters under aerobic conditions.
4. EPR evidence for flavin mononucleotide binding in mitoNEET
As a catalytic amount of flavin nucleotides is sufficient for reduction of the mitoNEET 
[2Fe-2S] clusters (Figure 4), we postulate that mitoNEET may have specific interactions 
with flavin nucleotides. In the experiments, mitoNEET is pre-incubated with 10-fold excess 
of NADP+, NAD+, FAD, or FMN in buffer containing 500 mM NaCl and 20 mM Tris (pH 
8.0) for 30 min under aerobic conditions. The samples are then reduced with freshly 
prepared sodium dithionite to fully reduce the redox co-enzyme and the mitoNEET [2Fe-2S] 
clusters for the EPR measurements, as only the reduced mitoNEET [2Fe-2S] clusters are 
paramagnetic and EPR visible [23, 40]. Any change of the EPR spectrum would reflect 
potential interactions between the reduced co-enzyme and the reduced [2Fe-2S] clusters in 
mitoNEET. Figure 5A shows that NADPH and NADH has very little or no effects on the 
EPR spectrum of the reduced mitoNEET [2Fe-2S] clusters (spectra 2–3), consistent with the 
idea that NADPH and NADH have a weak interaction with mitoNEET [29]. In contrast, 
incubation with FMNH2 produces a new EPR signal at g = 1.85 (spectrum 4), suggesting 
that FMNH2 may have a specific interaction with the reduced [2Fe-2S] clusters in 
mitoNEET. Interestingly, incubation with FADH2 does not have any significant effects on 
the EPR spectrum of the reduced mitoNEET [2Fe-2S] clusters (spectrum 5). Perhaps, the 
AMP moiety in FAD may obstruct the interaction between FADH2 and the [2Fe-2S] clusters 
in mitoNEET.
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MitoNEET is then incubated with increasing concentrations of FMN under aerobic 
conditions, followed by reduction with freshly prepared sodium dithionite. Figure 5B shows 
that as the concentration of FMNH2 increases from 0 to 200 µM, the amplitude of the EPR 
signal at g = 1.85 gradually increases with concomitant decrease of the EPR signal at g = 
1.94. Integration of the new EPR signal at g = 1.85 shows when 10 µM mitoNEET [2Fe-2S] 
clusters are incubated with 200 µM FMNH2, about 4 µM mitoNEET [2Fe-2S] clusters are 
converted to the ones with the EPR signal at g = 1.85. The relatively weak interaction could 
be due to the fact that both FMN and the [2Fe-2S] clusters in mitoNEET are in reduced 
state. However, attempts to isolate the mitoNEET-FMN complex from the incubation 
solutions were not successful. It appears that mitoNEET does not form a stable complex 
with FMN, similar as flavin reductase [38]. Nevertheless, the new EPR signal at g = 1.85 of 
the reduced mitoNEET [2Fe-2S] clusters at high concentrations of FMNH2 clearly suggests 
that mitoNEET has a specific interaction with FMN.
5. Molecular docking for the flavin mononucleotide binding in mitoNEET
To further explore the FMN binding in mitoNEET, we have used molecular docking 
approach. Our protocol for AutoDockVina-based Virtual Screening [37] is a modification 
from Garret M. Morris’ (The Scripps Research Institute, La Jolla, CA) [36]. The best 
docking models for the FMN binding in mitoNEET are shown in Figure 6A. For clarity, only 
one monomer in the mitoNEET dimer is shown with the bound FMN molecule. Each 
conformation of FMN in mitoNEET represents one docking model. In all docking models 
obtained, FMN always binds mitoNEET at the region between the transmembrane α-helix 
domain (not shown in Figure 6A) and the [2Fe-2S] cluster domain. The shortest distance 
between the [2Fe-2S] cluster and the bound FMN in mitoNEET is about 10 Å. A close 
examination of the FMN binding site in mitoNEET shows that His-39 and Lys-42 from 
chain 1 form electrostatic interactions with the phosphate group of FMN, while Ile-45 from 
chain 1 and Met-44 from chain 2 form hydrophobic interactions with the isoalloxazine group 
of FMN (Figure 6B).
To test potential role of the region between Arg-33 and Ile-45 of mitoNEET in binding 
FMN, we have constructed a mitoNEET mutant in which the residues between Arg-33 and 
Ile-45 are in-frame deleted. Deletion of the region between Arg-33 and Ile-45 has only a 
minor effect on the UV-visible absorption spectrum of the [2Fe-2S] clusters in the protein 
(Figure 7A). However, the deletion largely abolishes the specific interaction between 
FMNH2 and the reduced [2Fe-2S] clusters in mitoNEET (Figure 7B), suggesting that the 
region between Arg-33 and Ile-45 is at least partially responsible for the FMN binding in 
mitoNEET.
DISCUSSION
The [2Fe-2S] clusters in mitochondrial outer membrane protein mitoNEET are redox active 
with a redox midpoint potential (Em7) of 0 mV [21, 24]. However, cellular components 
responsible for reducing the mitoNEET [2Fe-2S] clusters are not fully understood. In 
previous studies, we reported that the mitoNEET [2Fe-2S] clusters can be reduced by 
biological thiols [22] or human glutathione reductase [23]. However, reduction of the 
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mitoNEET [2Fe-2S] clusters mediated by biological thiols [22] or human glutathione 
reductase [23] is slow, and must be carried out under anaerobic conditions [22, 23]. Here, we 
find that the reduced flavin nucleotides reduced by flavin reductase and NADH can rapidly 
reduce the mitoNEET [2Fe-2S] clusters under aerobic conditions (Figure 1). Flavins are 
ubiquitous redox co-enzymes in cells [41]. While flavin contents vary in different cell lines, 
riboflavin (3.1–5.7 amol/cell) and FAD (12–26 amol/cell) are found to be predominant 
flavins with a relatively lower content of FMN (2.7–3.4 atom/cell) in various cell lines [42]. 
Although riboflavin is considered the precursor of flavin nucleotides [41], we found that the 
reduced riboflavin, like the reduced FMN and FAD, can also rapidly reduce the mitoNEET 
[2Fe-2S] clusters under aerobic conditions (data not shown). In this context, we propose that 
flavin and flavin nucleotides may act as electron shuttles to mediate reduction of the 
mitoNEET [2Fe-2S] clusters, and that the redox state of the mitoNEET [2Fe-2S] clusters is 
directly controlled by the reduced flavin and flavin nucleotides.
Unlike the reduced flavin nucleotides, NADH or NADPH fails to reduce the mitoNEET 
[2Fe-2S] clusters under aerobic or anaerobic conditions [22, 23, 30]. However, we find that 
NADH can provide electrons to reduce flavin nucleotides via flavin reductase (Figure 1). 
When NADH is exhausted, the reduced mitoNEET [2Fe-2S] clusters are quickly oxidized by 
oxygen under aerobic conditions (Figure 2). Thus, the redox state of the mitoNEET [2Fe-2S] 
clusters may be ultimately controlled by intracellular NADH. In human cells, high glycolytic 
activity will lead to accumulation of NADH [28]. Excess NADH may be used by flavin 
reductase [43] to reduce flavin nucleotides which in turn reduce the mitoNEET [2Fe-2S] 
clusters on mitochondrial outer membrane. As the redox transition of the [2Fe-2S] clusters 
in mitoNEET is expected to modulate energy metabolism, iron homeostasis and production 
of reactive oxygen species in mitochondria [13], mitoNEET may act as a crucial link 
between the redox state of intracellular co-enzymes and mitochondrial functions.
The salient finding of this work is the specific interaction between FMN and mitoNEET. The 
observation that a catalytic amount of flavin nucleotides is sufficient to reduce the 
mitoNEET [2Fe-2S] clusters (Figure 4) led us to postulate that the reduced flavin 
nucleotides may have a specific interaction with mitoNEET in order to rapidly reduce the 
oxidized [2Fe-2S] clusters in mitoNEET. The EPR measurements show that incubation with 
the reduced FMN, but not the reduced FAD, indeed produces a new EPR signal at g = 1.85 
of the reduced mitoNEET [2Fe-2S] clusters (Figure 5). However, excess amounts of the 
reduced FMN are required to produce the EPR signal at g = 1.85 of the reduced mitoNEET 
[2Fe-2S] clusters, indicating that binding of the reduced FMN for mitoNEET is not very 
strong. It could be that both FMA and the [2Fe-2S] clusters in mitoNEET are reduced. 
However, attempts to isolate the mitoNEET-FMN complex under various redox states were 
not successful. Thus, FMN binding in mitoNEET could be transient, similar to that in flavin 
reductase [38]. We postulate that FMNH2 may rapidly reduce the oxidized [2Fe-2S] clusters 
in mitoNEET. Upon oxidation, FMN will have much lower binding affinity for mitoNEET 
and dissociate from mitoNEET. Nevertheless, at high concentrations of FMN, the new EPR 
signal at g = 1.85 (Figure 5) clearly suggests that mitoNEET has a specific interaction with 
FMN.
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Based on the molecular docking models (Figure 6), FMN most likely binds mitoNEET at the 
region between the transmembrane α-helix and the [2Fe-2S] cluster binding domain. The 
shortest distance between the isoalloxazine group of FMN and the [2Fe-2S] cluster in 
mitoNEET is about 10 Å (Figure 6A). Such an arrangement would allow rapid electron 
transfer from the reduced FMN to the oxidized [2Fe-2S] cluster in mitoNEET [44]. As 
reduction of the [2Fe-2S] cluster in mitoNEET is a single-electron event, reduced flavin 
nucleotide must form a semiquinone intermediate after delivering one electron to the 
[2Fe-2S] cluster in mitoNEET. However, we were unable to detect any semiquinone signals 
using EPR (data not shown). A simplest explanation could be that semiquinone 
intermediates may quickly reduce the other [2Fe-2S] cluster in the mitoNEET dimer (Figure 
6A). Evidently, additional experiments are required to illustrate the mechanism by which the 
mitoNEET [2Fe-2S] clusters are reduced by the reduced flavin nucleotides.
Using molecular docking approaches, Geldenhuys et al. previously identified two major 
binding sites in mitoNEET for type II diabetes drugs rosiglitazone and pioglitazone [45]. 
Site 1 consists of Lys-42 and Ala-43 from chain 1 and Met-44, Leu-47, Arg-76, His-90, and 
Thr-94 from chain 2, while site 2 consists of His-48, Ile-49, Trp-75, Arg-76, Ser-77, and 
Lys-78 from chain 1 [45]. The FMN binding site in mitoNEET shown in Figure 6A is 
distinct from site 1 and site 2 for type II diabetes drugs rosiglitazone and pioglitazone [45], 
but has some significant overlap with site 1. Because of the high insolubility of pioglitazone, 
the dissociation constant of the interaction between mitoNEET and pioglitazone was not 
determined (36). A more soluble pioglitazone analog, NL-1, has been shown to bind 
mitoNEET with a dissociation consistent of 7.4 µM (6). It is expected that pioglitazone or 
NL-1 will compete with flavin nucleotides for binding in mitoNEET. In previous studies, we 
reported that pioglitazone inhibits the reduction of the mitoNEET [2Fe-2S] clusters 
mediated by biological thiols [22] or by human glutathione reductase [23] under anaerobic 
conditions. Here, we have also found that pioglitazone and NL-1 can effectively inhibit the 
reduction of the mitoNEET [2Fe-2S] clusters mediated by the reduced flavin nucleotides 
under aerobic conditions (Wang & Ding, unpublished data). Further investigations on 
competition between pioglitazone or its analogs and flavin nucleotides for binding in 
mitoNEET may lead to discovery of new drugs that target mitoNEET to modulate energy 
metabolism in mitochondria.
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List of Abbreviations
Em7 redox midpoint potential at pH 7.0
EPR electron paramagnetic resonance
FMN flavin mononucleotide
FAD flavin adenine dinucleotide
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Fre E. coli flavin reductase
NADH nicotinamide adenine dinucleotide
NADPH nicotinamide adenine dinucleotide phosphate
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• A mechanism for redox transition of the mitoNEET [2Fe-2S] clusters is 
proposed.
• Reduced flavin nucleotides can rapidly reduce the mitoNEET [2Fe-2S] 
clusters.
• Flavin mononucleotide appears to have a specific interaction with 
mitoNEET.
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Figure 1. Reduction of the mitoNEET [2Fe-2S] clusters by reduced flavin nucleotides
A), UV-visible absorption spectrum of purified E. coli flavin reductase (Fre). Purified Fre 
(30 µM) was dissolved in buffer containing 500 mM NaCl and 20 mM Tris (pH 8.0). Insert 
is a photograph of the SDS-PAGE gel of purified E. coli Fre. B), reduction of the mitoNEET 
[2Fe-2S] clusters by the reduced flavin nucleotides. MitoNEET (containing 10 µM [2Fe-2S] 
clusters) (spectrum 1) was incubated with E. coli Fre (1 µM) (spectrum 2), Fre and NADH 
(50 µM) (spectrum 3), Fre, NADH and FMN (1 µM) (spectrum 4) in buffer containing 500 
mM NaCl and 20 mM Tris (pH 8.0) at room temperature under aerobic conditions. For each 
Landry et al. Page 13













reaction, the UV-visible absorption spectrum was taken after incubation for 2 min. C), EPR 
spectra of the mitoNEET [2Fe-2S] clusters. The samples were the same as in A). The EPR 
signal at g = 1.94 indicates the reduced mitoNEET [2Fe-2S] clusters. Data are representative 
of three independent experiments.
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Figure 2. Redox transition of the mitoNEET [2Fe-2S] clusters mediated by flavin nucleotides
A), redox transition of the mitoNEET [2Fe-2S] clusters. MitoNEET (containing 10 µM 
[2Fe-2S] clusters) was incubated with FMN (1 µM) and NADH (40 µM) under anaerobic 
conditions. Addition of Fre (1 µM) rapidly reduced the mitoNEET [2Fe-2S] clusters. Upon 
exposure to air, the reduced mitoNEET [2Fe-2S] clusters were quickly re-oxidized. Addition 
of additional NADH (100 µM) to the incubation solution under aerobic conditions re-
reduced the mitoNEET [2Fe-2S] clusters. The absorption peak at 458 nm indicates the 
oxidized [2Fe-2S] clusters of mitoNEET. The peak at 420 nm indicates the reduced [2Fe-2S] 
clusters of mitoNEET. B), UV-visible absorption spectra of the reaction solution at different 
time points. Spectrum 1, mitoNEET was incubated with FMN (1 µM) and NADH (40 µM). 
Spectrum 2, at 15 seconds after addition of Fre (1 µM). Spectrum 3, at 4 min after exposure 
to air. Data are representative of three independent experiments.
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Figure 3. Reduction of the mitoNEET [2Fe-2S] clusters in the presence of different 
concentrations of FMN
MitoNEET (containing 10 µM [2Fe-2S] clusters) was pre-incubated with E. coli Fre (1 µM) 
and different concentrations of FMN under aerobic conditions. NADH (50 µM) was then 
added to initiate the reaction. UV-Visible absorption spectra were taken every 40 seconds for 
280 seconds after addition of Fre. FMN concentration in the reaction solution was: 0 µM 
(A), 0.0125 µM (B), 0.025 µM (C), 0.05 µM (D), 0.10 µM (E), and 0.20 µM (F). The 
absorption peak at 458 nm indicates the oxidized [2Fe-2S] clusters of mitoNEET. The peak 
at 420 nm indicates the reduced [2Fe-2S] clusters of mitoNEET. The results are the 
representative of three independent experiments.
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Figure 4. Titration of flavin nucleotides in reduction of the mitoNEET [2Fe-2S] clusters
A), titration of FMN. MitoNEET (containing 10 µM [2Fe-2S] clusters) was pre-incubated 
with E. coli Fre (1 µM) and different concentrations of FMN under aerobic conditions. 
NADH (50 µM) was then added to initiate the reaction. After 4 min incubation, amounts of 
the reduced mitoNEET [2Fe-2S] clusters were measured from the UV-visible absorption 
spectra and plotted as a function of FMN concentrations in the reaction solution. B), titration 
of FAD. Same as in A), except FMN is replaced with FAD in the reaction solutions. The 
data represent the averages with standard deviation from three independent experiments.
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Figure 5. MitoNEET has a specific interaction with FMN
A), effect of the reduced co-enzymes on the EPR spectrum of the reduced mitoNEET 
[2Fe-2S] clusters. MitoNEET (containing 10 µM [2Fe-2S] clusters) was pre-incubated with 
no addition (spectrum 1), NADP+ (spectrum 2), NAD+ (spectrum 3), FMN (spectrum 4), or 
FAD (spectrum 5) in buffer containing 500 mM NaCl and 20 mM Tris (pH 8.0) at room 
temperature for 30 min. The concentration of redox co-enzymes in each incubation solution 
was 100 µM. After incubation, the samples were reduced with freshly prepared sodium 
dithionite (4 mM) and immediately frozen in liquid nitrogen. The EPR signal at g = 1.94 
represents the reduced mitoNEET [2Fe-2S] clusters. Incubation with FMN produced a new 
EPR signal at g = 1.85 of the reduced mitoNEET [2Fe-2S] clusters. B), EPR spectra of the 
mitoNEET [2Fe-2S] clusters in the presence of different concentrations of the reduced 
FMN. MitoNEET (containing 10 µM [2Fe-2S] clusters) was pre-incubated with increasing 
concentrations of FMN at room temperature for 30 min. After pre-incubation, the samples 
were reduced with freshly prepared sodium dithionite (4 mM) and immediately frozen in 
liquid nitrogen for EPR measurements. Data are representative of three independent 
experiments.
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Figure 6. Molecular docking models of FMN binding in mitoNEET
A), docking models of FMN binding in mitoNEET (PDB: 2QH7, Paddock et al. 2007). For 
clarity, only one monomer in the mitoNEET dimer was shown with the bound FMN 
molecule. B), predicted FMN binding site in mitoNEET. The phosphate group of FMN has 
electrostatic interactions with Lys-42 and His-39, while the isoalloxazine group of FMN 
forms hydrophobic interactions with Met-44 and Ile-45. Dotted lines represent hydrogen 
bonds in the mitoNEET-FMN complex.
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Figure 7. Deletion of the residues between Arg-33 and Ile-45 diminishes the interaction between 
mitoNEET and the reduced FMN
MitoNEET with deletion of the region between Arg-33 and Ile-45 was prepared using the 
site-directed mutagenesis. A), UV-visible absorption spectra of mitoNEET and mitoNEET 
mutant with the deletion. Spectrum 1, mitoNEET. Spectrum 2, mitoNEET mutant with the 
deletion. Insert is a photograph of the SDS-PAGE gel of mitoNEET and mitoNEET mutant 
with the deletion. Lane 1, mitoNEET. Lane 2, mitoNEET mutant with the deletion. B), EPR 
spectra of mitoNEET and mitoNEET mutant with the deletion after incubation with or 
without FMNH2. Purified proteins (containing 10 µM [2Fe-2S] clusters) were incubated 
with FMN (100 µM) for 30 min under aerobic conditions, followed by reduction with 
freshly prepared sodium dithionite (4 mM). The samples were then subjected to the EPR 
measurements. Spectrum 1, mitoNEET. Spectrum 2, mitoNEET after incubation with 
FMNH2. Spectrum 3, mitoNEET mutant. Spectrum 4, mitoNEET mutant with deletion after 
incubation with FMNH2. Data are representative of three independent experiments.
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